🇯🇵 Japan Country × Condition
urothelial carcinoma Clinical Trials in Japan
Active clinical trials for urothelial carcinoma with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT06310759
Recruiting
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
Enrollment
3,000 pts
Country
🇯🇵 Japan
Tampere University Hospital
View Trial → NCT06943521 Phase 1, Phase 2
Recruiting
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Enrollment
27 pts
Country
🇯🇵 Japan
Tanabe Pharma America, Inc.
View Trial → Frequently Asked Questions
How many urothelial carcinoma clinical trials are active in Japan?
There are currently 2 active clinical trials for urothelial carcinoma with sites in Japan, of which 2 are actively recruiting patients.
How can I join a urothelial carcinoma clinical trial in Japan?
To join a urothelial carcinoma clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are urothelial carcinoma trials in Japan?
Active urothelial carcinoma trials in Japan span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology